Who
Richard J. Benjamin
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Cerus; Director, Point Therapeutics.
In numbers
- Trades disclosed
- 136
- Buys
- 0
- Sells
- 33
- Bought
- $0
- Sold
- $6.4M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 20 Jul 2005
- Last trade
- 12 Mar 2026
- Last filed
- 16 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Mar 2026filed 16 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $169K101,740 at $1.66 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $169K101,740 at $1.66 | filing |
| 9 Mar 2026filed 10 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $76K40,426 at $1.88 | filing |
| 9 Mar 2026filed 10 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $76K40,426 at $1.88 | filing |
| 9 Mar 2026filed 9 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $76K40,426 at $1.88 | filing |
| 9 Mar 2026filed 9 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $76K40,426 at $1.88 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $49K24,235 at $2.01 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $49K24,235 at $2.01 | filing |
| 6 Mar 2026filed 9 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $49K24,235 at $2.01 | filing |
| 6 Mar 2026filed 9 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $49K24,235 at $2.01 | filing |
| 5 Mar 2026filed 10 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Code A | —55,220 at $0.00 | filing |
| 5 Mar 2026filed 10 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $126K61,233 at $2.06 | filing |
| 5 Mar 2026filed 10 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Code A | —55,220 at $0.00 | filing |
| 5 Mar 2026filed 10 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $126K61,233 at $2.06 | filing |
| 5 Mar 2026filed 9 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Code A | —55,220 at $0.00 | filing |
| 5 Mar 2026filed 9 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $126K61,233 at $2.06 | filing |
| 5 Mar 2026filed 9 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Code A | —55,220 at $0.00 | filing |
| 5 Mar 2026filed 9 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $126K61,233 at $2.06 | filing |
| 2 Mar 2026filed 4 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Code A | —264,000 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Code A | —264,000 at $0.00 | filing |
News
TransMedics Group (NASDAQ:TMDX) and Cerus (NASDAQ:CERS) Head-To-Head ContrastCERS · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name Richard J. Benjamin; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.